The global cell banking
outsourcing market is expected to reach USD 9.87 billion by 2022, according to
a new report by Grand View Research, Inc. Factors attributing towards this
anticipated market size include growing demand for gene therapy, stem cell therapy,
biopharmaceutical production that target on novel active sites.
Additionally, rise in
prevalence of oncology associated diseases and other infectious chronic
disorders are expected to promote cytological R&D in which cell banking
plays a pivotal role thereby driving growth. R&D for commercialization of
novel characterization and cryopreservation methods is also expected to
considerably enhance lucrative growth opportunities over the forecast period.
In depth research report on Cell Banking Outsourcing
Market
Further key findings from the report suggest:
·
Master cell banks accounted for
over 60% of revenue generated in 2014 owing to rise in these facilities across
the globe. Moreover, master cell banks are useful for the preparation of
working cell banks and thus find applicability in various research and
development perspectives for stem cell therapy and gene therapy thereby
resulting to segment growth.
·
Stem cells accounted for the
largest share with respect to revenue in cell banking market by cell type.
Factors attributive towards large share of this segment include availability of
stem cells from different organ origins and there consequent use in different
metabolic disorders.
·
North America accounted for the
largest share of this market for 2014, as there are a significantly high number
of research and development projects ongoing in the region related to
cytological investigation for proteomics, genomics, and drug and vaccine
development. Growing need for vaccines and biopharmaceuticals is also
anticipated to fuel the growth of this region.
·
Asia Pacific is expected to
witness significant growth in demand over the forecast period owing to increase
in number of supportive government initiatives pertaining to investments in
biotechnology sector. Additionally, ongoing R&D activities for cancer
treatment and fertility preservation facilitate the demand for cell banking
services.
·
Key participants in the cell
banking outsourcing market include BioReliance, BioOutsource (Sartorious), BSL
Bioservice, Cleancells, Charles River Laboratories, Covance, GlobalStem Inc.,
Lonza, PX’Therapeutics SA, SGS Life Sciences, Texcell, Toxikon Corporation,
Wuxi Apptec, Reliance Life Sciences, LifeCell International Pvt. Ltd.,
Cryobanks International India, Cryo-Cell International Inc., and CordLife.
·
Market participants are
involved in R&D for characterization of cell banks which include
introduction of efficient gene sequencing tests, karyology, and safety tests.
Grand View Research has
segmented cell banking outsourcing market on the basis of bank type, cell type,
phase of development of cell bank, and region:
Cell Banking Outsourcing Outlook, by Bank Type (Revenue,
USD Million, 2012 - 2022 )
·
Master Cell Banking
·
Working Cell Banking
·
Viral Cell Banking
Cell Banking Outsourcing Outlook, by Cell Type (Revenue,
USD Million, 2012 - 2022 )
·
Stem Cell Banking
·
Cord Stem Cell Banking
·
Embryonic Stem Cell Banking
·
Adult Stem Cell Banking
·
Dental Stem Cell Banking
·
IPS Stem Cell Banking
·
Non-stem Cell Banking
Cell Banking Outsourcing Phase Outlook (Revenue, USD
Million, 2012 - 2022 )
·
Cell Bank Storage
·
Master Cell Bank Storage
·
Working Cell Bank Storage
·
Cell Storage Stability Testing
·
Bank Characterization and
Testing
·
Safety Testing
·
Viral Cell Bank Safety Testing
·
Microbial Cell Bank Safety
Testing
·
Gene Expression Testing
·
Karyology Testing
·
Gene Sequencing Testing
·
Cell Bank Preparation
·
Master Cell Bank Preparation
·
Working Cell Bank Preparation
Cell Banking Outsourcing Regional Outlook (Revenue, USD
Million, 2012 – 2022)
·
North America
·
U.S.
·
Canada
·
Europe
·
Germany
·
France
·
UK
·
Asia Pacific
·
Japan
·
China
·
India
·
Korea
·
Singapore
·
Latin America
·
Brazil
·
Mexico
·
MEA
·
South Africa
Browse more research
reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment